Karim Kacimi, PhD
Global Policy Associate Director, NovoNordisk
Karim is senior specialist regulatory policy and intelligence. Karim is pharmacist and hold a PhD in Pharmacology. He has 12 years of regulatory experiences in both regulators and industry. As part of his current role, he has a focus on Post approval change and ICH Q12. He is an active member of different groups and task forces related to pharmaceutical quality system (PQS), ICH Q12 and Life cycle management of pharmaceutical products. This include the European Federation of Pharmaceutical Industries and Association (EFPIA) and The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA).